Fas gene mutations in mycosis fungoides: Analysis of laser capture-microdissected specimens from cutaneous lesions

Oncology

Volumn 67, Issue 2, 2004, Pages 130-134

  Nagasawa, Tomohiko ^a   Takakuwa, Tetsuya ^a   Takayama, Hitoshi ^a   Dong, Zhiming ^a   Miyagawa, Sachiko ^b   Itami, Satoshi ^a   Yoshikawa, Kunihiko ^a   Aozasa, Katsuyuiki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Fas gene; Microdissection; Mutations; Mycosis fungoides

Indexed keywords

ALANINE; ASPARTIC ACID; FAS ANTIBODY; FAS ANTIGEN; GENOMIC DNA; ISOLEUCINE; MEMBRANE PROTEIN; THREONINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANIMAL CELL; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DISEASE COURSE; EXON; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LYMPHOID CELL; MALE; MISSENSE MUTATION; MYCOSIS FUNGOIDES; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; SKIN DEFECT; T CELL LYMPHOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; ALANINE; ANIMALS; APOPTOSIS; ASPARTIC ACID; CARRIER PROTEINS; CODON; DNA, NEOPLASM; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOLEUCINE; LASER SURGERY; LYMPHOMA, T-CELL; MALE; MICE; MICRODISSECTION; MIDDLE AGED; MUTATION, MISSENSE; MYCOSIS FUNGOIDES; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; THREONINE; TRANSFECTION;

EID: 8344221333     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080999     Document Type: Article

References (18)

1. Nagata S: Apoptosis by death factor. Cell 1997; 88: 355-365.
2. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-243.
3. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. Immunol 1992; 148: 1274-1279.
4. Landowski TH, Qu N, Buyuksal I, Painter JS, Dalton WS: Mutations in the Fas antigen in patients with multiple myeloma. Blood 1997; 90: 4266-4270.
5. Gronbaek K, Straten PT, Ralfkiaer E, Ahrenkiel V, Andersen MK, Hansen NE, Zeuthen J, Hou-Jensen K, Guldberg P: Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity. Blood 1998; 92: 3018-3024.
6. Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, Park GS, Dong SM, Pi JH, Kim CS, Kim SH, Lee JY, Yoo NJ: Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene 1999; 18: 3754-3760.
7. Lee SH, Shin MS, Park WS, Kim SY, Dong SM, Pi JH, Lee HK, Kim HS, Jang JJ, Kim CS, Kim SH, Lee JY, Yoo NJ: Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder. Cancer Res 1999; 59: 3068-3072.
8. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA: Laser capture microdissection. Science 1996; 274: 998-1001.
9. Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S, Liotta LA: Laser capture microdissection: Molecular analysis of tissue. Science 1997; 278: 1481-1483.
10. Takakuwa T, Dong Z, Takayama H, Matsuzuka F, Nagata S, Aozasa K: Frequent mutations of Fas gene in thyroid lymphoma. Cancer Res 2001; 61: 1382-1385.
11. Dereure O, Levi E, Vonderheid EC, Kadin ME: Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: A possible mechanism for the accumulation of malignant T lymphocytes in the skin. J Invest Dermatol 2002; 118: 949-956.
12. Takakuwa T, Dong Z, Nakatsuka S, Kojya S, Harabuchi Y, Yang WI, Nagata S, Aozasa K: Frequent mutations of Fas gene in nasal NK/T cell lymphoma. Oncogene 2002; 21: 4702-4705.
13. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, et al: Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995; 268: 1336-1338.
14. Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, Zou TT, Shi YQ, Lei J, Cottrell J, Cymes K, Biden K, Simms L, Leggett B, Lynch PM, Frazier M, Powell SM, Harpaz N, Sugimura H, Young J, Meltzer SJ: Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet 1996; 14: 255-257.
15. Tamiya S, Etoh K, Suzushima H, Takatsuki K, Matsuoka M: Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells. Blood 1998; 91: 3935-3942.
16. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935-946.
17. Gronbaek K, D'Amore F, Schmidt K: Autoimmune phenomena in non-Hodgkin's lymphoma. Leuk Lymphoma 1995; 18: 311-316.
18. Kanavaros P, Bai M, Stefanaki K, Poussias G, Rontogianni D, Zioga E, Gorgoulis V, Agnantis NJ: Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas. Histol Histopathol 2001; 16: 377-386.